Cansino Biologics Inc. Posted 488.7 Million Yuan Net Loss in First Three Quarters of 2022

Cansino Biologics Inc. (康希诺生物股份公司) (688185.SH) reported a net loss of 488.7 million yuan in the first three quarters of 2022, reversing a net profit of 1.3 billion yuan for the same period in the previous year.

Meanwhile, the company posted 707.4 million yuan in revenue, down 77.1% year-on-year.

At the end of the reporting period, it had 11.5 billion yuan in total assets and 3.8 billion yuan in total liabilities, with a liability-to-asset ratio of 32.8%.